Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
DCF Valuation
Base-case fair value
€42.19
Intrinsic €56.26 · 25% MOS
Current price: €56.20
Base-case summary
Our base-case DCF for Clínica Baviera, S.A. (CBAV.XMAD) projects 10 years of free cash flow growth at 4.6% for years 1–5 and 2.3% for years 6–10, anchored to 4.6% historical FCF growth, then applies a 2.5% perpetual growth rate and a 8.0% discount rate. Starting from €45M in trailing free cash flow, this produces an intrinsic value of €56.26 per share. A 25% safety margin gives a fair value of €42.19, suggesting the stock is currently 25% overvalued against the €56.20 market price.
See 3 scenarios side by side
Conservative, Base, and Optimistic fair values, plus the sensitivity matrix and FCF history. Free account.
Model inputs
TTM Free Cash Flow
€45M
Cash & equivalents
€50M
Total debt
€71M
Shares outstanding
16M